| Literature DB >> 33574598 |
Arjun K Fontaine1,2, David G Ramirez3,4, Samuel F Littich3,5, Robert A Piscopio4, Vira Kravets4, Wolfgang E Schleicher4, Naoko Mizoguchi6, John H Caldwell7, Richard F Ff Weir3,5, Richard K P Benninger8,9.
Abstract
Previous studies have demonstrated stimulation of endocrine pancreas function by vagal nerve electrical stimulation. While this increases insulin secretion, expected concomitant reductions in circulating glucose do not occur. A complicating factor is the non-specific nature of electrical nerve stimulation. Optogenetic tools, however, provide the potential for cell-type specific neural stimulation using genetic targeting and/or spatially shaped excitation light. Here, we demonstrate light-activated stimulation of the endocrine pancreas by targeting parasympathetic (cholinergic) axons. In a mouse model expressing ChannelRhodopsin2 (ChR2) in cholinergic cells, serum insulin and glucose were measured in response to (1) ultrasound image-guided optical stimulation of axon terminals in the pancreas or (2) optical stimulation of axons of the cervical vagus nerve. Measurements were made in basal-glucose and glucose-stimulated conditions. Significant increases in plasma insulin occurred relative to controls under both pancreas and cervical vagal stimulation, while a rapid reduction in glycemic levels were observed under pancreatic stimulation. Additionally, ultrasound-based measurements of blood flow in the pancreas were increased under pancreatic stimulation. Together, these results demonstrate the utility of in-vivo optogenetics for studying the neural regulation of endocrine pancreas function and suggest its therapeutic potential for the control of insulin secretion and glucose homeostasis.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33574598 PMCID: PMC7878862 DOI: 10.1038/s41598-021-83361-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379